Exploring the Underlying Mechanism of Shenyankangfu Tablet in the Treatment of Glomerulonephritis Through Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation.

Abstract

Authors

• Meiling Jin
  Author Affiliations: College of Nursing, Consumer Health Informatics & Communication Laboratory (Ms Jin and Dr Kim), Research Institute of Nursing Science (Dr Kim), Seoul National University, Seoul, Republic of Korea.
• Wenwen Ren
  Department of Nephrology, Beijing Ditan Hospital,Capital Medical University, Beijing, 100015, People's Republic of China.
• Weiguang Zhang
  Department of Nephrology, Chinese People's Liberation Army General Hospital, Chinese People's Liberation Army Institute of Nephrology, State Key Laboratory of Kidney Diseases (2011DAV00088), National Clinical Research Center for Kidney Diseases, Beijing, 100853, People's Republic of China.
• Linchang Liu
  Department of Nephrology, Chinese People's Liberation Army General Hospital, Chinese People's Liberation Army Institute of Nephrology, State Key Laboratory of Kidney Diseases (2011DAV00088), National Clinical Research Center for Kidney Diseases, Beijing, 100853, People's Republic of China.
• Zhiwei Yin
  Department of Nephrology, Chinese People's Liberation Army General Hospital, Chinese People's Liberation Army Institute of Nephrology, State Key Laboratory of Kidney Diseases (2011DAV00088), National Clinical Research Center for Kidney Diseases, Beijing, 100853, People's Republic of China.
• Diangeng Li
  Department of Academic Research, Beijing-Chaoyang Hospital, Capital Medical University, Beijing, 100020, People's Republic of China.

Keywords

External Resources